<DOC>
	<DOCNO>NCT00279409</DOCNO>
	<brief_summary>The purpose pilot initiate program research development effective medication technique treat child ADHD refer `` partial '' `` non-responders '' standard stimulant treatment .</brief_summary>
	<brief_title>Treatment Children With ADHD Who Not Fully Respond Stimulants</brief_title>
	<detailed_description>We propose single site , ten week , pilot study 40 school age child , age 6-17 , Attention-Deficit/ Hyperactivity Disorder ( ADHD ) moderate great impairment ( C-GAS &lt; 55 ) show ADHD symptoms despite trial community primary care practitioner either two commonly use stimulant ( i.e. , either OROS-MPH ( Concerta ) mix salt amphetamine ( Adderall-XR ) ) . These child first classify three group : Group 1 , treat maximal dose stimulant partial response ; Group 2 , treat suboptimal dose stimulant show partial response , Group 3 , develop side effect limit continued treatment optimal dos stimulant . The next step enter child open , two week trial confirm treatment resistance . Group 2 , treat suboptimal dos , dosage increase maximum recommend stimulant dose . Group 1 , treat 4 week maximal dos stimulant , Group 3 , develop moderate severe drug-related side effect , switch class stimulant two week trial , unless try class . Those child maintain current class stimulant two week . At end two week , child rat ADHD-IV-RS Study Doctor . Those show moderate severe side effect respond exit trial treat openly . Children Group 2 continue show improvement week switch stimulant . All child Group 2 try stimulant child Groups 1 3 continue show mean score great 1 SD mean age refer Phase 2 . During phase 2 , randomize one two treatment arm eight week . The first treatment arm , `` simple treatment '' arm , consist parent training plus continued treatment stimulant tolerate yet decrease ADHD symptom enough meet criterion response , plus placebo matching aripiprazole . The second treatment arm , call `` combination '' arm , consist parent training plus continued treatment stimulant plus augmentation second generation antipsychotic ( aripiprazole ) . Aripiprazole ( Abilifyâ„¢ ) product FDA-approved market treatment schizophrenia treatment acute manic episode associate Bipolar I Disorder adult . However , aripiprazole also use treat child adolescent aggressive oppositional disorder standard clinical practice . We continue randomize patient 40 child ADHD become eligible enter Phase 2 .</detailed_description>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1 . English Spanish speaking parent/guardian . Parent/guardian child must able understand protocol . 2 . Primary diagnosis ADHD despite treatment stimulant primary care treatment provider . 3 . Nonresponder partial responder stimulant treatment . ADHD symptoms clinical impairment despite treatment stimulant ( include OROSMPH [ Concerta ] mixed salt amphetamine [ Adderall ] ) . 4 . IQ great 70 . 5 . The subject must school . 6 . The family must able attend weekly visit . 1 . Unable understand protocol follow study procedure . 2 . Subject well stimulant . 3 . Subjects show lack response minimal response stimulant due noncompliance take medication take suboptimal dos . 4 . Autism , Psychosis , Bipolar Disorder , Drug Abuse , significant suicidality , psychiatric disorder ( MDD , Anxiety Disorders , Eating Disorders ) addition ADHD require treatment additional medication therapy . 5 . The subject use abuse recreational drug positive urine toxicology screen ( except stimulant ) . 6 . The subject history physical , sexual , emotional abuse result clinically significant impact clinical presentation , potentially drive symptom ADHD . 7 . Females pregnant breastfeed positive urine pregnancy test . 8 . Sexually active female male agree use adequate birth control . 9 . Abnormal cardiac function . 10 . Subject take prohibited concomitant medication phase 1 phase 2 trial .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Attention Deficit Hyperactivity Disorder</keyword>
	<keyword>ADHD</keyword>
	<keyword>Treatment resistant</keyword>
	<keyword>Partial responder</keyword>
	<keyword>Non-responder</keyword>
	<keyword>Atypical Antipsychotic</keyword>
</DOC>